High Net Worth Advisory Group LLC Nuvalent, Inc. Transaction History
High Net Worth Advisory Group LLC
- $388 Million
- Q3 2025
A detailed history of High Net Worth Advisory Group LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 3,000 shares of NUVL stock, worth $294,510. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,000
Previous 3,000
-0.0%
Holding current value
$294,510
Previous $228,000
13.6%
% of portfolio
0.07%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding NUVL
# of Institutions
229Shares Held
59.8MCall Options Held
191KPut Options Held
306K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.77 Billion31.57% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$517 Million18.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$444 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$297 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.8MShares$176 Million0.02% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $4.22B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...